Glenmark’s subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseases, Health News, ET HealthWorld
Ichnos Sciences, Glenmark’s drug discovery subsidiary based in the US, on Tuesday said it has entered into an exclusive agreement with Spanish drugmaker Almirall to out-license its novel monoclonal antibody…
